Hereditary melanoma and the CDKN2A gene

For a small proportion of people with melanoma, hereditary predisposition plays a clear role.

One of the genes that is important in this regard is called CDKN2A.

You can think of a gene as a piece of hereditary information in your body. The CDKN2A gene normally helps to keep the growth and division of cells under control. If there is a hereditary change in this gene, also known as a mutation, that protection works less well. As a result, the risk of melanoma increases.

What is p16-Leiden?

In the Netherlands, one particular hereditary change in the CDKN2A gene is relatively common. It is called p16-Leiden.

People with this change have a clearly increased chance of developing melanoma during their lifetime. They can also develop more than one melanoma.

With p16-Leiden, the risk of pancreatic cancer is also increased. Dutch studies cite a lifetime risk of about 15 to 20 per cent for carriers. This also means that most carriers do not develop pancreatic cancer.

Does being a carrier mean you will develop cancer?

No.

A hereditary change in the CDKN2A gene means that the risk is increased. It does not mean that someone will definitely develop melanoma or pancreatic cancer.

Even within families with the same hereditary change, there can be big differences. One person may develop cancer while another does not, or only later in life.

What does this mean for your family?

A hereditary change in the CDKN2A gene can be passed on from parent to child.

A child of someone with a hereditary CDKN2A change has a 50 per cent chance of inheriting that change. Brothers and sisters may also have a 50 per cent chance, depending on the situation in the family. A clinical geneticist can explain what this means for relatives.

Whether someone has the change can be found out through DNA testing. For relatives who have not had melanoma themselves, this is usually possible from young adulthood. Whether and when someone wants to know is a personal choice.

When might genetic testing be considered?

Not everyone with melanoma has a hereditary predisposition. Genetic testing through a clinical geneticist can be discussed when there are signs of a hereditary cause, for example if:

– two first-degree relatives have had melanoma, at least one of them before the age of 50
– someone has had three or more melanomas
– someone developed melanoma before the age of 18
– someone has had both melanoma and pancreatic cancer
– two first- or second-degree relatives have had melanoma, and pancreatic cancer or cancer of the head and neck area has also been diagnosed in a first- or second-degree relative

First-degree relatives are parents, brothers, sisters and children. Second-degree relatives include, for example, grandparents, grandchildren, uncles and aunts.

Your treating doctor or GP can discuss with you whether a referral makes sense. Where possible, someone who has had melanoma themselves is tested first.

What check-ups may be recommended?

People with a hereditary CDKN2A change are usually advised to have their skin checked regularly and to keep an eye out themselves for new or changing spots.

According to the Dutch guideline, carriers have a skin check with a dermatologist twice a year. First-degree relatives who have not (yet) had DNA testing are advised to have their skin checked at least once a year from the age of 12.

In addition, carriers may be offered annual pancreatic screening from the age of 40, at a specialised centre. This is usually done with an MRI scan or an internal ultrasound. Such a check makes it possible to find abnormalities at an earlier stage, but it does not guarantee that pancreatic cancer will always be detected in time.

Which check-ups are appropriate depends on the exact hereditary change, the family history and the personal situation.

The information in this article is based on Dutch medical guidelines. Recommendations may differ in other countries.

Why is smoking particularly discouraged?

For carriers of p16-Leiden, smoking is particularly unfavourable. Research shows that in this group, smoking is linked to a higher risk of several types of cancer, including cancer of the pancreas, the lungs and the head and neck area, such as the mouth and throat.

If you have symptoms such as a sore in your mouth that does not heal, difficulty swallowing or persistent hoarseness, it is wise to see your GP in good time.

This topic is personal for us as well

This topic is especially close to us because Arnaud carries a hereditary change in the CDKN2A gene.

When Arnaud’s hereditary predisposition became clear, new questions also came up about what this means for him and for our family.

Is anything in this explanation still unclear?

Sources